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Background: Regardless of healthcare technology advancements and widespread use 
of barcode identification technology, patient identification errors still occur. Several 
studies and benchmark programs have shown that patient misidentification is the 
leading cause of transfusion-associated reactions and fatalities. Therefore, it is 
recommended to use barcode technology to reduce and possibly eliminate avoidable 
blood transfusion errors. However, none of the available studies so far has investigated 
the compliance with using barcode technology to identify patients and specimens 
during the process of specimen collection for transfusion. Aims: This project aims are 
(1) Identify the prevalence of noncompliance in barcode scanning assisted patient 
identification at the pre-analytical phase during specimen collection at Sidra Medicine; 
and (2) Evaluate the causes of barcode scanning noncompliance; and finally (3) 
Develop quality improvement action plans that could reduce noncompliance events. 
Materials and Methods: The frequency of blood typing specimen collection 
noncompliance events between January 1, 2019 and December 31, 2019 were retrieved 
from the Laboratory Information System (LIS) module of Transfusion Medicine 
Laboratory report. Quantitative and qualitative analyses of data included stratification 




performed. Accordingly, process improvement plans specific to each department 
involved in specimen collection were established. Results: Collection compliance rates 
of a total of 6387 blood typing specimens were evaluated. Full barcode scanning 
identification of both patient and specimen was utilized in only 33.6% of total 
collections during the baseline study period. The remaining two thirds of collections 
were override events, in which no barcode scanning at all represented 31.3%, and the 
sample accession label was scanned but not the patient armband in 32.3% of total 
collections. In addition, there were significant differences between phlebotomists and 
nurses with more phlebotomists performing the full scanning and specimen label 
scanning only, while more nurses obtained specimens without scanning either 
identification of patient or specimen (p<.001). Conclusion: Our study highlights poor 
utilization of barcode scanning to verify patient and specimen identification during 
specimen collection. We launched a quality improvement project that identified the 
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CHAPTER 1: INTRODUCTION 
Sidra Medicine is a tertiary healthcare provider in Qatar offering service to women and 
children. Sidra Medicine is accredited by The Joint Commission International, and 
acquired College of American Pathologists accreditation for the clinical laboratories. 
Barcode-based identification system is an integral part of delivering high levels of 
patient care and managing patient safety at Sidra.  Hence, continuous improvement 
initiatives should be implanted to study the practice of patient identification.  
 
Research Questions: 
a) What is the prevalence of patient and specimen identification non-
compliance during specimen collection?  
b) What are the causes and root-causes of non-compliance? 
c) How to improve patient and specimen identification process during 
specimen collection at Sidra Medicine? 
 
Research Objectives: 
a) Identify prevalence of barcode scanning assisted patient identification 
noncompliance at the pre-analytical phase during specimen collection 
b) Evaluate the causes of barcode scanning noncompliance 
c) Outline quality improvement action plans to reduce noncompliance events  








CHAPTER 2: LITERATURE REVIEW 
 Patient safety during blood transfusion has received considerable attention due 
to its adverse effects on mortality as a result of transfusion errors. Medical errors occur 
in distinct areas of healthcare practice such as patient misidentification, transfusion of 
blood, product labeling, and the dispensing and distribution of medication and blood 
products. Therefore, operational processes  that ensure correct identification takes place 
during blood transfusions have been recommended. Reduction of errors using different 
system approaches have been advocated over the years as one of the methodologies to 
simplify the process and reduce reliance on human entry. As a result, the use of 
computer technology has increasingly transformed blood administration, empowering 
health systems to develop necessary infrastructure that support proper functioning of 
patient identification for blood transfusion processes. Barcode technology is a growing 
technology for streamlining blood transfusion processes that provides a primary criteria 
through which healthcare systems can significantly reduce human errors, enhance 
patient identity, and enforce accurate administration of medication and blood 
components. 
 
2.1 Historical Patient Identification Procedures and the Clerical Errors History  
 Increasing concern about blood transfusion is derived from the need to reduce 
avoidable transfusion errors in patient identification [1]. In the US, fatal 
misidentification errors during transfusions occur in 1 in 600,000 to 1 in 800,000 
transfusions, with the error incidence in the UK is  335 for every 5.5 million of red cells 
transfused [1]. According to Ohsaka et al, the risk of non-infectious complications 
related to transfusion care is at least 100 times greater than that of acquiring hepatitis C 




of Medicine, in the US, in 1999 revealed that hospital mortality resulting from 
medication errors were 98,000 patients annually, underlining a major public health 
concern related to transfusion safety [3]. On the other hand, data from World Health 
Organization (WHO) indicates that there is 1 out of 300 probability of a patient to be 
harmed due to medical errors, with the Food and Drug Administration (FDA) 
estimating that half of these medical errors are caused by misidentifications [4]. 
Although not all errors are preventable, around 95% harmful blood and medication 
identification errors can be avoided to mitigate the rate of infections and other harmful 
adverse effects [5]. To support the need for patient identification during blood 
transfusion, Sandhu et al. revealed that 11% of all transfusion deaths in the US are 
caused by mislabeling of blood components by phlebotomists and improper 
identifications [6]. As a result, safety of blood transfusion is a growing priority for 
different health systems.  
 
 The historical path to patient identification systems during blood transfusion has 
oscillated between manual and technological methodologies, with advancements 
developing effective and innovative approaches to blood transfusion safety concerns. 
According to Bolger & Moss the prioritization of blood transfusion safety in the UK 
led to the formation of the Serious Hazards of Transfusion (SHOT) in 1996 to monitor 
the adverse effects and events of blood transfusion [7]. On the other hand, the Institute 
of Medicine assessed that the cost of healthcare is around $3 billion, with over $1 
million allocated as avoidable costs during blood transfusion. Consequently, the Joint 
Commission has enacted improved accuracy of patient identification on hospitals 
accreditation programs to prioritize patient safety [8]. The history of automated systems 




processes. Increasing production volumes and the complex work flow in blood 
transfusions necessitated quick asset movement through the blood lifecycle that 
challenged the conventional laboratory setup for blood transfusion [8]. The need to 
permit seamless workflow and desirable reading experience necessitated 
technologically-based support that corresponded with automation. For example, 
University of Iowa Hospitals and Clinics (UTHC)  in an attempt to reduce reliance on 
human data entry and hence the error-prone to manual double-checking of blood 
product processes initiated automated patient identification manuals [9]. On the other 
hand, Uy et al, , and using a survey from the health Information and Management 
System Society (HIMSS) from 5,400 non-federal US hospitals, delineated that manual 
patient identification  caused majority of patient identification errors, with insufficiency 
in blood labeling [3]. With approximately 30% of transfusion service errors taking place 
during pre-issuing, there was an increasing need to address the selection of blood 
samples, transposition of labels, transcription of errors and selection of pre-transfusion 
testing [2]. As a result, appropriate specification of patient identification increased the 
adaptation of automation of transfusion services, necessitating development of 
electronic systems during the pre and post-transfusion processes. 
 
 Understanding patient identification in transfusion medicine and the growth of 
automation services requires advance assessment of variation of errors in the practice. 
According to Kaufman et al , errors leading to wrong transfusions can occur at any step 
of blood collection and transfusion [10]. Incidences of errors during blood collection 
are highly prevalent validating that repetitive tasks pose consistency problems to human 
or manual transmission. Insufficient patient data collection is directly attributed to 




provides no accepted taxonomy for identifying errors during blood transfusion [6]. 
However, a multidisciplinary approach offers systematic links at different specimen 
collection and analysis points that can be used to address transfusion errors. Apart from 
the collection errors in the transfusion service, the role of professionals in handling and 
treating blood samples and specimen may give rise to clerical errors that affect the 
conformity percentage of the patient identification. Failure to undertake frequent 
identity during critical procedures affected the distribution of accurate blood 
identification procedure [11]. On the other hand, Ohsaka et al., while measuring the 
pre-transfusion procedure at the bedside of Japanese patients, found out that 
mistransfusion attributable to clerical errors compromised the safety and administration 
of blood protocols [2]. Blood banks are in continuous operation on 24 hours basis, any 
minor clerical error can cause fatal harm, making demands for automated systems valid 
[12]. As a result, a system approach that simplifies the transfusion service and obviates 
the incidences of errors has the potential to substantially increase the safety, accuracy 
and productivity of patient transfusion procedure. 
 
2.2 Emergence of Electronic Systems – Scanners, Barcode, and Wristbands  
 Electronic systems in transfusion medicine follows the mandate to improve 
patient safety as a priority area in reducing blood transfusion morbidity cases. The 
Health Information Technology for Clinical Health (HITECH) promotes the 
development of real-time monitoring health informatics to improve efficiency and 
safety of clinical procedures [12]. The Transfusion Medicine Service (TMS) provides 
a range of multiple regulations to enforce and regulate automated blood bank 
applications that govern blood collection, matching, delivery and self-administration 




tools in transfusion has facilitated availability and movement of different electronic 
tools applicable in patient identification and blood labeling, reducing the prevalence of 
clerical errors and improving the accuracy and utilization of laboratory services [12]. 
With reporting policies and administrative guidelines supporting accurate identification 
to foster quality improvement in transfusion medicine, electronic systems are poised at 
bridging the identification gaps of manual systems and improving the adaptability and 
acceptance of technology by hospitals and clinicians [13]. Therefore, implementation 
of automated identification systems is a sequential process to bridge the identification  
complexities in the conventional blood bank procedures. 
 
 Different automated systems have been developed as practical means to reduce 
misidentification problem in healthcare. Barcode technology is one of the most visible 
patient identification tools integrating automation [14]. According to Sharma et al., 
barcode scanners use a technology that provide on-demand customized labels that 
transform and validate pre and post-blood collection and processing activities [12]. 
Barcode technology is infused into patient identification using products such as 
scanners, wristbands, portable printers and computer-based scanners [15]. The 
objective of transfusion medicine is availing the right blood to the right patient and 
ensuring compliance and verification of functions along the blood supply chain [12]. 
Barcode technology has the propensity to match patient’s identification data before and 
after administration of blood-related activities. Barcoding practices are effective 
intervention to reduce human error due to the flexibility in linking specimen labels with 
identified patients. Electronic barcoding provides an identification protocol through the 
entire testing process from ordering, specimen collection, analysis, and reporting, 




product-based barcode options, automation of the transfusion service can take the form 
of point-of-care systems. According to Snyder, barcode technology provides an 
effective methodology for tracking and labeling capabilities throughout the transfusion 
process through its myriad of options such as scanners, wristbands and barcodes [15]. 
The implementation of this technology offers quality improvements in safety, privacy 
and accuracy of transfusion activities by reducing human errors and improving patient 
identification [15]. In regard to healthcare productivity, automation of the transfusion 
process using barcode technology increases clinicians and patient’s satisfaction rates 
[15]. 
 
 As the most common automated patient identification tool, barcode scanner has 
a high degree of accuracy; therefore, it is an ideal method to reduce medical errors in 
transfusion medicine. The barcoding system was enforced by the Center for Disease 
Control and Prevention (CDC) in 2010 as the best practice to reduce the incidences of 
identification errors and improvement of patient specimen accuracy [6]. With the usage 
of the barcode scanner increasing from eight to 38 percent between 2007 and 2015, the 
effectiveness of this automation tool in improving communication and collaboration in 
transfusion medicine was established [6]. The application advantages of barcode 
scanners originates from their computational abilities and from the potential to be 
combined with other passive manual and automated systems [4]. The ability to update 
and  integrate information contained in other automated systems increases the accuracy, 
continuity, and functionality of medical information, developing interfaces through 
which specimens can be described and tested in the course of the transfusion process 
[13]. According to Coustasse et al., linking of patient identification and other patient 




provide a systematic review of transfusion information to manage and track blood 
products [16]. 
  
Progress in use of automated wristbands in the transfusion process has been 
made, providing flexible technology for patient identification. According to Latham et 
al. the wristband intervention has increased usage along monitoring needs of the 
transfusion process with the acceptability of the automation dependent on the 
compliance standards of the hospital [11]. Wristbands with the right identification 
protocol such as name, hospital identification number and other details improved the 
communication and appropriateness of medication and blood protocol from admission 
to discharge [17]. According to Tase & Tronchin, the identification process enabled by 
wristbands is easily understood and implementable increasing its incorporation value 
by transfusion clinicians [17]. However, there are anecdotal observations on the use of 
wristbands that change the engagement of the tool in patient identification. According 
to self-evaluations undertaken by Latham et al, wristbands had high levels of mistrust 
among patients and clinicians, necessitating continued supervision and training to 
promote its coverage. [11]. Similarly, Tase & Tronchin found that misidentification of 
patient still permeated hospitalization using wristbands indicating potential hazards of 
mislabeling and medication [17]. Absence of overall standards and institutional 
protocol affected the quality of performance protocols and necessitated active 
contribution of health professionals and patient’s families [17]. As a result, it is essential 
to improve the compatibility levels of wristbands in the transfusion service to increase 





The effectiveness of wristbands is derived from its ability to integrate other 
forms of technology to improve accuracy. Automated wristbands can be integrated with 
radio frequency identification (RFID) to improve connectivity and ability to use 
wireless networks to identify patients, avoid delays and poor administration [13]. RFID 
is the next advanced innovation in patient identification due to its capability in tracking, 
automating and monitoring location and movement of patients and data [4]. RFID can 
increase the safety of the transfusion medicine by providing intelligent services to 
wristbands to accumulate continuous knowledge throughout the blood bank path. A 
study performed in 4 Italian hospitals found  that embedding an RFID transfusion 
system on wristbands made significant improvements in errors and work reduction 
times [16]. As a result, there are multiple benefits to blood bank operations when RFID 
technology is infused to automated wristbands to monitor and track patient and clinician 
compliance to transfusion safety guidelines. In addition, barcode technology can be 
assigned to wristbands to link  patients to other computerized systems within the 
laboratory setup [15]. The barcode technology on wristbands aids in verifying data 
displayed and assessing whether the barcodes on the wristband match the blood 
specifications of the patient [2]. With eye-readable  barcodes for identification, 
wristbands offer verification protocol to measure the compatibility features of provided 
patient data, making it an effective checking procedure during pre and post-transfusion 
services. 
 
2.3 Barcode Implementation Studies  
 The use of barcode automation technology in transfusion medicine is not only 
a future requirement in healthcare but also a tested practice with improvement rates 




Iowa Hospitals (UTHC) replaced the manual blood system and automated collection 
and care of specimens using a barcode system [9]. The methodology change was 
proposed as a tool for error reduction, increasing productivity, accuracy of patient 
identification, and specimen matching. An analysis of the system activity before and 
after the adoption of automation found out that barcoding was 30 times likely to catch 
identifications errors than the manual system, reflecting a major improvement and 
relative lesser risk compared to the previous process [9]. A Haemonetics blood tracking 
system introduced by the National Patient Safety Agency in the UK prompted by the 
need to ensure the correct blood protocol was  implemented. The system reduced the 
number of incident report errors  significantly [7]. Additionally, the experiment 
revealed that blood transfusions were  performed in a timely manner, with active 
checking of delays by nurses, supported by the barcoded wristbands [7].  
 
A prior study has explored the benefits of using barcode scanning of specimen 
accession over manual entry of patient information [18]. Duteau implied that the use of 
scanners improved efficiency in delivering patient care with less involvement of manual 
steps [18]. Therefore, patient safety practices can be enhanced [18]. Similarly, Murphy 
discussed applied strategies to overcome patient identification barriers and outcomes 
[19]. Nurses were satisfied with the use of portable devices to identify patients, and 
there were reduced [19] . This further implies the benefits of utilizing the electronic 
systems in improving patient safety and patient care services.   
 A prospective before-and-after investigation undertaken by Spain et al. in 
Queensland, Australia found improvements in 90.4% of the subjects measured using an 
armband barcode scanner [20]. The study intended to measure the frequency of correct 




technology intervention [20]. The specimen integrity improved due to collection of 
desirable patient identification information and the reduction of clerical deficiencies 
from the labeled tubes [20]. Studies on the long-term improvement and sustainability 
of barcode technology in transfusion medicine has been promoted by the need to 
identify safety r  measures in larger hospitals with high patient numbers. Quality 
improvements from a barcode-based transfusion management (BCTM) system was 
tested in a 3,000 bed tertiary hospital handling more than 60,000 blood transfusions 
covered by 2,500 nurses annually [21]. Over a period of six years  from 2011 to 2017, 
it was found that the error rate decreased to 0.001%, with the only incidence among the 
68, 324 blood samples was caused by incorrect labeling [21]. The reported results 
indicate the important of the barcoded system to make quality changes in a large 
healthcare system and subsequent reduction of transfusion errors. 
  
A study undertaken by the Serious Hazards of Transfusion (SHOT), a health 
agency in England, revealed that approximately 70% of blood sample errors originated 
from the bedside, with a large observable improvement detected after monitoring audits 
[2]. The blood transfusion guidelines in British blood laboratories were also updated to 
incorporate pre-transfusion barcode automations at the bedside aimed at initiating safe 
and accurate blood collection and handling protocols [2]. A meta-analysis study 
reported that errors related to barcode identification methods were rare and generally 
preventable indicating the beneficial outcomes of reduced workflow [15]. With respect 
to production, barcode systems have economic benefits for hospitals. Studies reviewing 
the satisfaction levels of patients and clinicians found that barcoding had reduced 
workflow processes and enabled targeted performance measurement, shortened patient 




Medicine Best Practices Initiative (LMBP)  study conducted by Sandhu et al. in 2017  
on 12 studies published between 1980 and 2015 communication and collaboration 
between laboratory and clinical staff post barcode implementation [6]. They found that 
seven studies indicated improvement in communication and collaboration, that apart 
from reducing error incidences, improved patient satisfaction [6]. As a result, barcode 
automated interventions decreased treatment delays and costs leading to improved 
patient satisfaction [6]. Adoption of infusion automation also increased provider 
satisfaction due to the technical organization and improved tracking of testing protocols 
that elicit support and positive behavior [22]. As a result, reduction of dissatisfaction of 
the quality, safety and accuracy of blood transfusion services among patients and 
clinicians is a justifiable ground for implementation of barcode-related system in 
transfusion medicine. 
 
 To justify the redundancy of paper requisition forms in blood centers, a BCTM 
system was introduced in a 3000-bed tertiary hospital where it was found out that mean 
number of near-miss incidents reached zero per quarter for 18 quarters between  2011 
to 2017 [21]. The deployment of specific patient identification (ID) barcode wristband 
and labeling discontinued the paper requisitions provided a cost effective method for 
laboratory tools to collect blood specimen. In measuring the improvement rates for 
labeling, a survey in UK hospitals addressing clinicians to label critical blood 
specimens found excellent agreement between critical blood information and quick 
response (QR) barcodes [23]. Barcodes enhanced identification of blood samples by 
de-cluttering the extensive information displayed on transitional label essential in 
collection and analysis of blood specimens. In  a study conducted by Ohsaka et al. in 




Japanese Red Cross Blood Center found out that automation improved the 
compatibility levels of pre-transfusion data providing an active methodology to track, 
monitor and authenticate patient blood identification details [2]. Improvement rates in 
transfusion samples labeling have facilitated the emergence of international labeling 
standards such as the ISBT 128 that enforces the tracking, movement and availability 
of blood products across hospitals and international borders [12]. To validate the use of 
barcodes to eliminate errors, Hachesu et al. advocated the use of training to increase the 
efficiency of transfusion clinicians [24]. A descriptive study conducted by Kaur et al  
to measure the responses of training in improving capabilities for transfusion medicine 
found improvement in bedside blood compatibility reflecting accuracy of post-blood 
assessment activities [25]. With barcode system making improvements in 
hemovigilance and blood safety, there are expected effects that can be used to improve 
a monitoring and quality standards of blood centers and hospitals [26]. As a result, these 
improvements address key quality and safety issues in transfusion medicine and 
promote the standardization of automated blood applications. 
 
2.4 Sidra Medicine  
2.4.1 Accreditation  
Sidra Medicine is a specialist hospital providing high level of care to women and 
children in Qatar. An ambitious vision is stated on the organization’s site “Sidra 
Medicine is a beacon of learning, discovery and exceptional care, ranked among the 
top academic medical centers in the world” [27]. The hospital is keen to deliver 
exceptional care to patients delivered with high levels of standards and safety. Sidra 
Medicine has achieve a number of international accreditations. Sidra Medicine was 




following a successful initial CAP inspection, clinical laboratories became CAP 
accredited on May 2019 [29].   
 
2.4.2 Laboratory Information System (LIS) 
Sidra Medicine utilizes Cerner software to streamline its clinical workflows. Cerner 
modules offer extensive services that facilitate management of the hospital’s laboratory 
information system. This includes ordering tests, documenting specimen collection, log 
in of samples when received in the clinical laboratories, and viewing or reporting 
results. Cerner software is interfaced with a barcode-based identification system. 
 
2.4.3 Specimen Collection at Sidra Medicine  
Specimens are mainly collected by phlebotomists and nursing staff at Sidra 
Medicine. The process starts with confirming the patient’s identity verbally using at 
least two identifiers – by asking the patient to state their full name and date of birth 
(DOB). This practice has been implemented as per JCI standards (IPSG.1) [30], since 
Sidra Medicine is a JCI accredited institute [28]. The collector then opens the specimen 
collection wizard in PowerChart, a module of Cerner Pathnet, and verifies patient 
identity on the system. Electronic verification, positive patient identification (PPID), is 
accomplished by scanning patients ID bands with a barcode reader. This confirms that 
the correct patient record is accessed in PowerChart. The requisitions are subsequently 
retrieved and specimen labels are printed; sometimes, collectors pre-print labels before 
admitting outpatients into phlebotomy rooms. The collector inspects the requisition 
and/or labels, chooses the proper the container, and collects specimens accordingly. 
The preprinted labels are attached to the appropriate tubes in the presence of the patient 




change the order status from ‘Dispatched’ to ‘Collected’. Collector’s identifier (staff 
ID), collection date, and collection time are documented in the system upon validation 
of collection. Hence, positive accession identification (PAID) is accomplished.  
 
When specimen collectors bypass positive identification of patient wristband, 
specimen accession labels or both, the system marks an override event. Thus, Cerner 
categories specimen collection status into the following:  
1. Dispatched: Specimens that have not been collected remain in dispatched 
status until collection is documented in the system. In addition, collectors 
cannot be identified.  
2. Collected: Specimens that are collected and signed-in electronically.  
The events of collection are tabulated in Cerner Container Inquiry under Event List. 
The specific details include : 
I. Positive Patient Identification (PPID) 
i. PPID Collection: This event indicates that patient’s wristband 
was scanned into the Specimen Collection Wizard. 
ii. PPID Override: This event reflects that specimen collector 
bypassed scanning of patient’s wristband.  
 
II. Positive Accession Identification (PAID) 
i. PAID Collection: This event specifies that collector used 
barcode reader to scan specimens’ labels to validate collection.  
ii. PAID Override: This event confirms that specimens’ labels were 





The collected specimens are placed in the pneumatic tube system, and are sent directly 
to the laboratory. Specimen Reception staff visually check the specimens and send them 
to their designated laboratories. Thus, there is minimal handling of the specimens from 
collection to receiving and processing. 
 
2.4.4 Specimen Receiving at Transfusion Medicine Laboratory (TML) 
Specimen Reception in Department of Pathology, Sidra Medicine, is responsible 
for receiving specimens from the different wards across the hospital, and from an 
external entity, Qatar Foundation Clinic (QF Clinic). Using Cerner Specimen Log-In, 
phlebotomists scan each accession label into the app against the barcode readers to log 
in the specimens. The status changes from ‘Collected’ to ‘In Lab’. All specimens are 
sent to the designated laboratory sections for testing.  
 
Specimens received in ‘Dispatched’ status lack collector identifiers, collection date 
and collection time. Instead, the system by default associates the specimen-receiving 
staff with the collection in Cerner Specimen Log-In. The collection status changes from 
‘Dispatched’ to ‘In Lab’ upon clicking ‘Log In’. This would show that the receiver 
collected and received the sample at the same date and time.  
 
An exception is formulated by TML to acknowledge receiving their own specimens. 
Specimen Reception delivers TML samples to the Specimen Receiving Bench, and 
TML technologist logs in the samples in Cerner Specimen Log-In. This is done to 
monitor and control Turn Around Time (TAT) of processing blood samples, according 
to their priorities, from the time of receiving them in TML to the time of reporting the 





2.4.5 Types of Tests Processed by Transfusion Medicine Laboratory (TML) 
in 2019  
There are two classifications of orderable tests for TML: primary tests and ancillary 
tests. Primary tests are blood typing (ABORh), antibody screening, cord blood testing 
and direct antiglobulin test (DAT). These are predominantly requested by physicians, 
while ancillary tests are mainly ordered by TML technologists to the previously 
collected specimens. The ancillary tests, or add-on tests, include antibody 
identification, antibody titration, and elution. These tests are performed to supplement 
the positive results of antibody screening and DAT.  
 
Blood typing and antibody screening are ordered together, and sent to the lab in one 
specimen tube per patient. Typing is performed to determine the blood group of an 
individual, while the screen is done to detect unexpected antibodies circulating in the 
patient bloodstream against red blood cells (RBC) [31]. The unexpected antibodies 
developed from exposure through blood transfusion or pregnancy are termed 
alloantibodies [32].  Autoimmune conditions attribute to the production of antibodies 
targeted against an individual’s own red cells, autoantibodies [33]. DAT is a test to 
detect coating of patients red cells by antibodies or for investigations of Hemolytic 
Disease of the Fetus and Newborn (HDFN) [34] [35]. Hence, DAT is performed on 
cord blood and venous blood samples . Positive results of antibody screen tests and 







2.5 Overview of the Present Study  
To date, no study was conducted to check if healthcare providers are using the 
implemented technology to document specimen collections. At Sidra Medicine, the 
system has been implemented before hospital activation, and thus, its use should be 
assessed. By studying the prevalence of improper patient identification and specimen 
accession identification at Sidra Medicine, and identifying the root cause, we intend to 
improve patient identification process and ensure compliance by specimen collectors 
across Sidra Medicine. The study framework is constructed according to the quality 
improvement Six Sigma initiative, DMAIC. Thus, the outcomes of the project can be 





CHAPTER 3: MATERIALS AND METHODS 
 
3.1 Ethical Compliance  
 IRB applications have been submitted to Sidra Medicine IRB and QU-IRB, and 
have been examined by both boards. SIDRA IRB and QU-IRB have made the 
determination that this is a quality improvement project that does not require IRB 
review and approval (Appendix C).  
 
 3.2 Research Design  
A multimethod approach including the use of quantitative metrics derived from 
electronic medical records, and informal interviews was utilized. No identifying 
information of patients or the specimen collectors (staff involved in blood collection) 
has been captured as it serves no purpose in the study.  
 
3.2.1 Setting 
The study has been conducted at Transfusion Medicine Laboratory (TML), Department 
of Pathology, Division of Hematopathology, Sidra Medicine. 
 
3.2.2 Participants  
Data have been retrieved from the collection of all blood specimens for blood typing at 
Transfusion Medicine Laboratory between January 1, 2019 to December 3, 2019. Test 
patients (non-real patient records created to validate the system), external quality 






3.3 Data Collection  
3.3.1 Quantitative Analysis  
Several quantitative metrics has been used to identify and evaluate the following, 
retrospectively:  
1. Number of blood typing specimens processed in 2019 
2. Number of specimen collectors roles (based on their position) 
3. Prevalence of specimens collection status which are categorized as below:  
a. Specimens collected per policy/procedure (both patient ID and specimen 
accession ID verified electronically) 
b. Specimens with partial compliance (either patient ID or specimen 
accession ID verified electronically, and the other verified manually)  
c. Specimens collected using override mode (neither patient ID nor 
specimen accession ID verified electronically but manual verification 
performed and documented on system) 
d. Specimens received in dispatched status (collection was neither 
documented electronically nor manually) 
4. Number of rejected dispatched specimens by TML 
 
3.3.2 Qualitative  Analysis  
A qualitative approach of informal interviews and a survey has been developed 
in this project. Informal interviews were conducted to identify possible barriers and to 
better understand the workflow of different health care workers involved in performing 




3.3.2.1 Informed Consent 
Because there is no requirement for survey respondents to identify themselves, 
since this study falls under the quality improvement category, it will not involve 
informed consent. Both the interview and the survey are categorized as parts of quality 
improvement project, based on anonymous and voluntary contribution, to avoid any 
potential coercion. 
 
3.3.3 Study Framework  
The study was carried out using the DMAIC (Define, Measure, Analyze, Improve and 
Control) approach of Lean Six Sigma retrospectively. 
1. Define: Data of ABORh specimens processed by the Transfusion Medicine 
Laboratory was extracted from Explorer Menu module in Cerner PathNet; 
Cerner PathNet is Sidra Medicine’s laboratory information system. Data was 
exported and analyzed in Excel to filter out test and external quality assessment 
specimens after which all patient identifiable information were removed. 
Collector roles were identified after which all employee specific information 
were removed.   
2. Measure: Prevalence of noncompliance events, by role and by location were 
calculated.  
3. Analyze: Quantitative tools including statistical tools were employed to analyze 
and interpret the results. In addition, informal interviews and audits were 
conducted to identify the reasons for patient identification and accession 
identification noncompliance incidents.  
4. Improve: Process improvement plans were developed based on the outcomes 




5. Control: An internal audit was executed to assess and control the analytical 
phase. This involved examining rejection and processing of dispatched samples 
received by Transfusion Medicine Laboratory post-implementation of new 
acceptance criteria. 
 
3.4 Confidentiality  
3.4.1 Data Security  
The initial extracted data contained patient and staff identifiers. Data was assessed 
at Sidra Medicine to remove test patients and proficiency testing specimens. Then, all 
patient identifiers (patient name, Medical Record Number, Date of Birth, and specimen 
accession number) were deleted permanently as only the collection status of the 
specimens is required for the study. The staff ID was used to identify the job 
position/title of each staff then, all staff IDs were removed completely from the data. 
The final data only contained specimen collection status, specimen collection location 
(the wards at which the specimens were collected), and the position of the collector.   
 
Because this data is being generated from the Laboratory information system it is 
already available to others. There is no separate information being obtained. The initial 
dataset will be kept on a lab restricted shared drive and rapidly de-identified.  Data was 




Since participants are specimens with deleted patient and staff identifiers, 




information was ensured at the initial stage of the project before proceeding to analysis 
of data. Any identifier, patient and staff, was deleted from the data sheet. Patient 
identifiers served no purpose in this study. As for staff ID, the identifier was removed 
after indicating the position of the collector. Data analysis was conducted once de-
identified data was established. 
 
3.5 Statistical Analysis 
Inferential analysis was performed on the results to obtain an understanding of 
interdependence of specimen collection compliance and role of collector. Specifically, 
due to the data type, and that collection of samples are mutually exclusive, chi-square 


















CHAPTER 4: RESULTS 
4.1 Tests Performed at Transfusion Medicine Laboratory (TML) in 2019 
A total of 14443 primary tests were performed at TML in the calendar year 2019. 
Steps for inclusion and exclusion criteria and the proportions of the tests processed in 
TML are illustrated in Figure 2. The majority of these tests are blood typing and 
antibody screening, with similar proportions of 45.4% (6559) and 45.2% (6525), 
respectively (Figure 2). The difference in numbers between the two tests is due to 
some samples received from QF clinic where only blood type is requested. In 
addition, patients not admitted for blood transfusion, surgery, prenatal screening, 
oncology services, with no immunocompromised conditions, hemolytic anemias, 
hemolytic disease of the newborn (HDN) or any type of hemoglobinopathies, do not 
require antibody screen testing.  
 
An average of 7.8% (1133) of the tests were performed on cord blood samples, 
and DAT was processed in 1.6% (225) of the total tests.  
The chart (Figure 2) represents approximately 99.0% (14443) of the data from the 
original data report (14595). The remaining data of about 1.04% (152) tests were 
excluded from analysis, as indicated in Figure 1. This is because the original data set, 
with a total of 14595 tests, included tests performed on proficiency testing samples 
and test patients (non-real patients). Particularly, the proficiency testing surveys are 
received from CAP, to which the results are submitted. This compromised 0.38 % 
(56) of the total tests processed throughout 2019. Among the excluded data, 0.66% 
(96) of the tests were from test patients in efforts to validate a system, workflow or 





Figure 1. Flowchart showing selection of specimens in the study. Specimens linked to 























4.2 Pilot Audit Overview  
The initial phase of this study involved a pilot audit to get an overview on the 
frequency of noncompliance events during specimen collection in the month of January 
2019. The noncompliance events were defined as any barcode scanning override of 
either patient ID or specimen accession labels in Specimen Collection Wizard, and the 
failure to document specimen collection electronically or manually. We included blood 
typing (ABO Rh) data only in the analysis to avoid duplication of results. As stated 
previously, antibody screening is typically ordered with blood typing per patient. 
Moreover, cord blood testing is an initial determination of the newborn’s blood group 
but not the confirmatory test, while DAT testing on cord samples is performed to 
diagnose HDFN [35]. Hence, data sets from antibody screen, DAT and cord blood 
testing were removed, in addition to all tests from proficiency testing samples and test 
patients (Figure 1).   
 
4.2.1 Classification of Collection Events  
In the pilot study (January 1, 2019 to January 31, 2019), a total of 481 blood 
specimens were received and processed by TML for blood typing. Collection events 
were specified according to the use of Specimen Collection Wizard and electronic 









Table 1. Classification of Collection Events  
Use of Specimen 
Collection Wizard 




 PPID PAID 
   
Full Scan Yes Yes 
Patient Scan Only Yes No 
Tube Scan Only No Yes 
No Scan No No 
Not Used Received in Dispatched Status 
*Verification performance denoted the use of the barcode scanner to validate identifications  
 
 
4.2.2 Categorization of Collections by Roles 
With reference to Table 2, ABO Rh samples were largely obtained by phlebotomists 
(60.3%), followed by nurses from different departments (35.8%), adding up to an 
average of 96.0% of total January collections. There were 5/481 (1.0%) collections 
extracted by staff with unknown roles (Table 2). Their user ID are known but their 
profiles could not be found in the Employee Directory and their positions from Cerner 
database could not be retrieved. Thus, their roles could not be identified.   
 
 
Table 2. Numbers of ABORh specimen collections per role in January 2019  
Job classification/Role Numbers of Samples 
Collected  
% 
Phlebotomist 290 60.3 
Nurse  172 35.8 
Anesthetist 3 0.62 
Anesthesia Technologist 1 0.21 
Other  1 0.21 
Unknown Rolei 5 1.0  
Unknown Collectorii 9 1.87 
i. Unknown role: user ID known but profile missing  






Specimen Collection Wizard was not utilized in only 9/481 (1.87%) collections 
(Figure 3). The remaining collections, exceeding 98%, were obtained using the wizard, 
in which the majority involved override events of either one identification verification 
or both. Hence, 66/481 (13.7%) were collected per procedure/policy where both patient 
wristband and specimen accession were barcode scanned.  
 
Interestingly, nurses were the largest group overriding both PPID and PAID 
(60.6%, 131), relative to 35.6% (171) of no scan collections by phlebotomists (Figure 
3). Opposite relative proportions were apparent in more phlebotomists performing more 
of the full scan and sample accession scanning only in comparison to nurses (78.8% vs 









Figure 3. Specimen collection events by roles. The figure illustrates breakdown of 
collection events by collectors roles of January 2019. Numbers in columns indicate 
frequency of the event. Colors differentiate the collectors roles.  
 
 
4.3 Analysis of Complete Audit  
4.3.1 Overview  
The audit period was extended to include all blood typing specimens collected in 2019 
calendar year in an effort to monitor compliance throughout the year and plan 
improvement strategies accordingly. Data analysis was carried out using data extracted 
from the modified report.  
4.3.2 Summary of Results  
There were 6632 ABORh specimens in the year reviewed. Of these, 73 were 
test patients or external quality assessment specimens, leaving 6559 patient specimens 


























specimens were unknown (Figure 4a). Results were further analyzed after removing 
data of specimens collected by staff of unknown roles. Thus, the total number of 
datasets evaluated were 6387.  
The rates of collections per role were proportionately similar before and after 





Figure 4. Comparison of collections per role (a) with unknown roles data (b) without 
































4.3.3 Stratification of collections by event type and roles  
With reference to Figure 4b, Nurses collected 41.2% (2633) of the specimens 
while phlebotomists collected 57.2% (3652). Anesthetists and anesthesia technologists 
documented only 0.26% (17) of samples, while collections by other roles account for 
0.05% (3) of total collections. Specimens collected in dispatched status (collectors not 
documented) represented 1.28% (82).  
Collection status/events of all samples (6387) were specified, and their 
proportions among total collections were measured (Table 3). As indicated in Table 3, 
only 33.6% of specimens collected utilized the full barcode scanning identification of 
the patient and specimen. Close to a third (31.3%) had no barcode scanning at all and 
in another third (32.3%) the accession label of the sample was scanned but not the 
patient armband (Table 3). 
Overall, there were variations between nurses and phlebotomists in verification 
of patient identify and documentation of collections during blood typing specimen 
collection. Table 3 demonstrates more phlebotomists were completing collections with 
full scanning (44.8% vs 19.6%), and accession labels scanning only (41.4% vs 20.9%). 
However, nurses failed considerably to scan both patient ID and accession labels 










Table 3. Comparison between Rates of Specimen Collection by Nurses and 
Phlebotomist relative to the Collection Events* 
 





Full scan (33.6%)** 515 (19.6%)*** 1635 (44.8%) 
Patient scan only (1.53%) 66 (2.51%) 32 (0.88%) 
Tube scan only (32.3%) 550 (20.9%) 1510 (41.4%) 
No scan (31.3%) 1502 (57.1%) 475 (13.0%) 
*Collection events significantly differed between nurses and phlebotomists (χ2 (3) = 1448.99, p<.001) 
**values in parentheses represent percentage relative to total number of collections in 2019  
***values in parentheses represent percentage relative to the total number of collections per specific  
      role 
 
 
The relative proportions of compliance by nurses and phlebotomists throughout 
2019 were individually examined. Numbers of collections obtained by nurses following 
identification protocols slowly increased from 7.56% in January 2019 to 37.0% in 
December 2019 (Figure 5a). Phlebotomists performance, otherwise, showed a 
substantial increase in specimen collections with both patient and sample accession 










Figure 5. Relative proportions of compliance within (a) nurses (b) phlebotomists. 
Override events included the sum of collections with no scanning of either patient and 
specimen identifications or both.  
 
 
4.3.4 Stratification of dispatched collections by event type and roles  
There were 1.28% of specimens which arrived in the laboratory with no collection 
documentation (Figure 4b). Blood typing test of all samples (82) were run by the 
medical technologists. Data extracted from the report does not include 
rejected/cancelled samples. Dispatched samples were sent to the laboratory with 
different priorities and from multiple locations within the hospital wards. Routine 





























majority of the samples came from outpatients of QF Clinic and in-patients in 




Figure 6. Breakdown of dispatched samples received by (a) sample priority (b) patient 


































4.4 Potential Causes of Barcode Scanning Noncompliance 
A risk assessment of noncompliance to specimen collection protocols are described 




Figure 7. Possible causes for noncompliance to specimen collection identification 
protocols. The fishbone diagram indicates 5 major categories of causes resulting in 









4.5 Improvement Strategy Plan 
4.5.1 Pre-analytical Phase  
A survey was designed to identify root causes of identification noncompliance during 
specimen collection, and will be sent to staff involved in specimen collections during 
the first half of 2020 (Appendix B). Survey results analysis will be shared with the 
corresponding clinical groups to target the contributory factors, and to establish 
improvement plans accordingly.  
4.5.1.1 Survey Content  
The survey (attached in Appendix B) will collect details on the causes that 
contribute to non-use of barcode scanning during patient identification and specimen 
collection documentation. The survey is an electronic, internet based survey, with 11 
questions about respondent’s position, training in blood collection process, number of 
collections and the factors influencing the override of the electronic identification. This 
is not a validated questionnaire but was designed after initial audit of workflow and 
interview with staff knowledgeable about the process and possible barriers.  A link to 
the survey will be emailed to all staff involved in blood collection. 
 
4.5.1.2 Informed Consent 
The survey will not involve informed consent as discussed in Chapter 3 (section 
3.3.2.1). 
 
4.5.2 Analytical Phase 
As directed by TML Medical Director at Sidra Medicine, TML would reject all samples 
received in dispatched status regardless of priority, unless the tube was signed manually 




classification of patient health condition, age of patient, and status of patient (VIP 
patient) when their samples arrive to TML without electronic or manual 
acknowledgement of collection.  
 
Clinical wards would be informed of sample rejection, followed by submitting 
a report to the events surveillance/reporting system. This decision was effective on 
April 17, 2019, and communicated to TML medical technologists through email and 
during morning huddles. TML specimen receiving procedure was amended to reflect 
the new rejection criteria.  
 
Additionally, a new cancellation code was added to Cerner’s drop-down list of 
cancel reason as of September 5, 2019. This code, ‘LAB-Collection not documented’, 
would be used when cancelling samples received in dispatched status, instead of using 
the code ‘other’ and writing a comment to reflect the reason.  
 
Moreover, an ongoing audit (monthly-basis) of processing blood typing samples 
sent in dispatched status was established, as part of an internal audit of TML’s quality 
management system.  
 
4.6 Processing of Dispatched Samples in TML (Post-implementation Audit) 
An internal audit was conducted to investigate adherence of TML medical technologists 
to the new specimen rejection rule on dispatched samples. Cancelled specimens data 
are extracted from a different report as TAT report includes data of processed samples 




sections. No samples received in dispatched status were rejected prior to the decision 
implemented on April 17, 2019.  
 
As indicated in Table 4, all dispatched samples received in April were 
processed; none was cancelled. One sample per month, in May, and July till December, 
was rejected, except in June where 2 dispatched samples were cancelled (Table 4).  
 
 
Table 4. Proportions of Cancelled Dispatched Samples in TML since April 17, 2019 
Month Numbers of 
cancelled samples 
Total number of 
received samples i 
% 
April 0 4 0.0 
May  1 10 10.0 
June 2 9 22.2 
July  1 6 16.7 
August 1 4 25.0 
September 1 10 10.0 
October 1 4 25.0 
November 1 7 14.3 
December 1 8 12.5 
i.Total number of received samples is the sum of processed dispatched samples (Appendix A) and 




Cancel codes (cancel reason) and comments of all rejected dispatched samples were 








Table 5. Cancel Codes Selected and Comments added to Rejected Dispatched Samples  
Month Numbers of 
cancelled samples 
Cancel reason Cancel comment 
May  1 LAB-other Dispatched 
June 2 LAB-other Dispatched 
July  1 LAB-other Dispatched 










Senior informed nurse (No ID 












CHAPTER 5: DISCUSSION 
 
Automated systems in transfusion medicine have found prominence as the 
general healthcare sector increases its intake of technological advancements. With high 
morbidity and morbidity prevalence associated with unsafe blood practices, transition 
from manual blood collection and handling practices to automated tools provided viable 
solutions to the problem.  
 
Sidra Medicine is an advanced hospital in Qatar accredited by a number of 
global agencies including JCI and its clinical laboratories are accredited by CAP. As 
such, Sidra Medicine has integrated Cerner software and barcode-based identification 
system to achieve and maintain high accuracy of patient identification standards. 
Therefore, metrics to evaluate the practice of electronic patient identification during 
specimen collection are needed.  
 
In efforts to comply with patient safety requirements, we have assessed the 
prevalence of the use of barcode scanning to positively identify patient and specimen 
labels during collection of blood typing samples. The implications of these findings are 
discussed below. In addition, we highlighted possible factors that contributed to 
barcode scanning noncompliance, and initiated improvement plans to reduce 
noncompliance events.  
 
Transfusion Medicine Laboratory at Sidra primarily performs blood typing, 
antibody screening, DAT and cord blood testing. Blood typing and antibody screening 




transfusion specimen for most of the cases since the patients are predominantly 
pregnant women, and children with critical conditions. Both orders accounted for 
90.6% of all tests performed in TML during 2019 (Figure 2). In addition, DAT samples 
were the least collected and processed at TML (1.6%), followed by cord blood testing 
(7.8%) (Figure 2). DAT is a case-by-case test ordered for patients with suspected 
antibodies-bound red cells circulating in their bodies. Thus, the proportion of 
processing DAT as compared to blood typing and antibody screening is much lower. 
Cord blood typing at Sidra is directly proportional to the number of live births. There 
were 152 samples associated to non-real patients records encompassing test patients 
(96) and proficiency testing (56) (Figure 1). Being a CAP-accredited laboratory, TML 
receives and processes proficiency testing samples on a regular basis. The results are 
submitted to CAP to determine the performance of the specific tests. 
 
While previous studies have focused on evaluating the numbers of mislabeled 
specimens pre and post implementation of an electronic system [36] [37] [38] [39], we 
identified a novel mechanism to audit the use of barcode scanning during specimen 
collection to authenticate identification of patient and specimen labels. 
 
First, we performed a pilot study to understand the frequency of override events 
after detecting several samples in dispatched status. In order to facilitate quantification 
and analysis of collection events, we classified them based on the use of technology to 
verify patient identification and accession label identification (Table 1). For instance, 
if specimen collector scanned patient wristband and sample accession label into the 




The study enclosed 481 blood typing samples performed in January 2019, of 
which 13.7% only were fully scanned (both patient identification and specimen 
collection were scanned into the collection wizard) (Figure 3). With reference to Table 
2, more than 95% of total January collections were obtained by phlebotomy and nursing 
staff. A total of 4 samples were drawn by anesthetists and anesthesia technologist 
(Table 2). Anesthesia staff tend to collect pre-transfusion samples before or during 
surgeries depending on surgical intervention and/or risk of bleeding. 
 
The results indicated a high level of noncompliance to patient identification and 
specimen accession identification during specimen collection among all identified 
collectors roles. Thus, this necessitated the need to investigate the prevalence of the use 
of barcode-based identification system during specimen collection.  
 
Clustering data into collections by specific roles and locations was feasible. A 
generated TAT report in the system, was modified to capture collection events and 
integrate staff ID of the collector. The main challenges encountered during the pilot 
audit were:  
1. Analysis of results  
Analysis was time consuming due to the use of simple excel functions to evaluate the 
results. Moreover, the role of each specimen collector was obtained from Employee 
Directory per sample in the dataset. Hence, the roles were manually transcribed into the 
dataset. Similarly, the collection event of each sample was examined individually 
through Container Inquiry module, and added into the dataset.  
2. Some staff roles could not be identified using staff ID.  




1. Audit results were unsatisfactory leading to extending the audit time frame.  
2. The turn-around-time (TAT) report within Cerner PathNet, from which the data 
was extracted, would be modified to include the user Identification of the staff 
who documented the specimen collection and whether the patient identification 
was barcode scanned (PPID Collection) or overridden (PPID Override) and 
whether the sample accession number was scanned (PAID collection) or not 
(PAID Override).  
3. Unknown staff roles would be omitted from 2019 data analysis. Most likely the 
unknown roles are linked to staff who left Sidra before data analysis. Thus, their 
profiles were not found in either Employee Directory or Cerner database.   
 
The findings from the pilot study enables designing a better approach of collection and 
analysis of 2019 data.  
 
Collectively, our findings revealed that specimen collection staff performed 
poorly in following procedure/policy of documenting collections in the Specimen 
Collection Wizard throughout 2019. Regardless of increasing proportions of full scan 
throughout the year reviewed, higher number of noncompliance were evident (Table 3, 
Figure 5). This accounted for two-thirds of all blood typing collections during 2019. As 
depicted in Figure 4, similar proportions were maintained before and after removing 
data of specimens collected by unknown roles from dataset. This is because collections 
by unknown roles represented only 2.6% of total collections (Figure 4).  
 
Noncompliance to positive patient identification and specimen accession 




transfusion related-risks associated with patient misidentification [40] [41] [42]. A 
report prepared by SHOT, reported 908 near miss cases attributable to Wrong Blood in 
Tube (WBIT) in the years 2016-2018. These errors could have consequently lead to 
ABO-incompatible transfusion [43]. ABO-incompatibilities have proven to cause 
detrimental outcomes including transfusion reactions and death [44] [45]. A study by 
O’Neill et al. indicated significant reduction in incidents of WBIT and mislabeled 
specimens (by 73.5%; p ≤.0001, and by 84.6%; p ≤.0001) [46]. The results were 
attained after successful implementation of strict specimen labelling policy [46]. Thus, 
more effort needed to improve specimen collection practices, and positive patient 
identification at Sidra Medicine to eliminate avoidable sources of errors.  
 
In the present study, nurses collected majority of specimens without scanning 
both patient identification and specimen accession (57.1%), while phlebotomists 
obtained most specimens with full scanning practice (44.8%) (Table 3). The results of 
this study indicate that nurses tend to omit steps of specimen collection scanning more 
than phlebotomists. The data contributes a clearer understanding of non-phlebotomy 
personnel conducting more preanalytical collection errors relative to phlebotomists, as 
presented by Rooper et al [47]. The investigators examined prevalence of specimen 
rejection stratified by acceptance/rejection criteria, patient care areas, and collectors 
roles; they found that 85% of rejected specimens were collected by nurses while 
phlebotomists were responsible for collecting 4% of rejected specimens [47]. 
Collectively, the findings of our study and literature suggest that initiatives are required 





Interestingly, rates of full scanning marked increasing proportions relative to all 
types of override events, over the period of the year reviewed, but were significantly 
disproportionate between nurses and phlebotomists (p<.001) (Table 3, Figure 5). A chi-
square test of independence was calculated comparing the frequencies of compliance 
events among nurses and phlebotomists; the results indicated highly significant 
difference between the two groups (p<.001) (Table 3). Overall, nurses were involved 
in more than 80% of override incidents of total collections extracted by nursing team 
(Table 3). Conversely, phlebotomists performed fewer override practices (55.2%) with 
total compliance (performing full scan) in 44.8% of samples (Table 3).   
 
At the start of the study, phlebotomists were more involved in override events 
(>50%) compared to full scanning (Figure 5b). The proportions changed dramatically 
during fourth quarter of 2019, in which full scanning was performed in more than 60% 
of specimen collections, and exceeding 90% in December (Figure 5b). In comparison, 
statistics of full scan collections by nurses were fluctuating between 9% and 14% in 
months of May to August (Figure 5a). Compliance rates by nurses improved slightly 
over the last 4 months of 2019 with an average of 34.8% (Figure 5a). Although 
improvement in full scanning by phlebotomist is apparent, efforts in changing 
behaviors towards the end of 2019 should be studied.  
 
It is notable that there was a decreasing trend in the numbers of override events 
by the end of 2019 (Figure 5). TML strictly rejected any specimen received with no 
documentation of collection in the system despite order priority, and was effective mid-
April 2019. Nonetheless, a concern circulates on accepting samples with positive 




identification (PAID). This is because there is a chance of retrieving wrong patient 
profile in PowerChart, and with pre-printing of labels, resulting in WBIT. This has been 
specifically addressed in a study by Nuttel et al. [48], in which more transfusion-related 
near miss cases were discovered using computerized identification systems. The results 
were correlated with the findings of a similar study, and implied that 
preventable/avoidable errors in patient identification are recurrent [48] [49].  
 
Similar and identical first and/or last names are very common among Arab 
communities. Consequently, more risks are associated with misidentification of 
patients if two-identifiers standard is not followed [50]. One study, conducted by 
Henneman et al., examined patient verification during order entries in a prospective 
approach [51]. The design of the study involved test patients with similar names [51]. 
Results suggested that all participants (care providers) verified patient identification 
with patient names only; the medical record number was not checked [51]. Thus, 
clinical personnel tend to miss the two-identifiers rule. Hence, a similar behavior can 
occur during specimen collections with PPID override at Sidra. Considering such 
practices, the use of barcode-based identification system prevents misidentification of 
patients with similar names as patients are verified by scanning their ID wristbands.  
 
It is difficult to reject samples with PPID override due to high prevalence of 
specimen received with PPID override (Table 3). For instance, urgent requests for blood 
transfusions could impede the process of scanning patient wristband during collection 
of blood typing samples. Thus, probability of receiving such samples would be high. 
Moreover, Sidra Medicine is a specialized women and pediatrics hospital at which 




imposes challenges on healthcare providers in handling those patients, and increases 
the need to override PPID.  
 
Clinical laboratories need to invest further in quality measures to improve 
patient safety across the hospital.  However, as long as collector identifiers are not 
documented, TML will reject the sample regardless of priority or patient condition. 
Strict adherence to acceptance criteria is required by the American Association of 
Blood Banks (AABB) [52]. As per the standards, published by AABB, a sample with 
no traceable collector identification is considered a mislabeled sample, and must be 
rejected accordingly with no exceptions [52]. In accordance with common standards, 
patients without blood type history or a valid blood type sample will receive 
uncrossmatched group O blood in case of emergency [52]. Type-specific blood will be 
issued once a valid sample, which is electronically documented or manually 
acknowledged, is received and processed by TML. This practice saves patients from 
blood grouping errors and potentially ABO incompatibilities when samples are not 
collected per policy.  
 
We identified possible causes of overriding patient and specimen accession 
identifications, and summarized them in Figure 7. To some extent, we were able to 
associate few noncompliance cases with the factors contributing to them. First, 
anesthesia team collected 0.26% of the specimens without verifying either patient 
identification or specimen accession (Figure 4, Appendix A). Medical Director of TML, 
Sidra Medicine, has communicated with leaders of anesthesia team via email, and found 
some operating rooms lack barcode scanners/readers (Technical). Hence, collections 




and hardware are available at QF Clinic (Technical). This explains the receiving of 
18/19 QF Clinic samples in dispatched status. One sample was documented with both 
PPID and PAID override, as the phlebotomist documented collection upon returning to 
Specimen Reception in Sidra Medicine.  
 
Additionally, we have reviewed blood collection procedures from Phlebotomy. 
Even though the SOP clearly detailed use of Specimen Collection Wizard, workflow 
failed to reflect verification of non-electronic collections by manually signing the tube 
with collector identifier (Procedure). Additionally, indicated diagnosis for most 
dispatched samples for blood typing were ‘Surgery’ and ‘Unwell’ (Figure 6c). We 
speculate that failing to use the Specimen Collection Wizard might be due to urgency 
of blood transfusion requests (Patient). Moreover, we attempted to use the Specimen 
Collection Wizard against a test patient. An alert was prompted only when specimen 
accession was not scanned in; hence, this confirms that the wizard does not constrain 
overriding positive patient identification, and specimen accession identification 
(Technical).  
 
Furthermore, system downtime is a definite contributor to override collections 
as Cerner application is not accessible during that time; every step is recorded manually 
(Technical). In September 2019, Cerner was upgraded, and thus, the upgrade was 
validated before re-implementation and use. Once the upgrade got confirmed for 
functionality, all procedures were recorded back into the system, including specimen 
collection. In addition, it was observed that some nurses claimed they were not aware 
of the new rejection process (rejection of dispatched samples by TML) (Staff, 




observational assessment was performed by phlebotomy seniors or clinical nurse 
leaders post hospital activation, other than assessment during competency training 
(Management).  
 
Moreover, there is no quality control check on how to perform collection of 
specimens. The physical assessment is done through phlebotomists and nurses annual 
competency. We have not evaluated their competencies as it should be done annually. 
The purpose of the study was to get actual figures of noncompliance after receiving 
many samples at TML that were not appropriately documented in the system. As a 
result, we examined and identified the frequencies of compliance to the process of 
specimen collection and documentation using a data-driven approach. Regarding the 
handling of specimens from collection to receiving, the transport of specimens occurs 
with very minimal handling due to the use of the pneumatic tube system. Hence, the 
specimens arrive directly to the laboratory post collection, and Specimen Reception 
staff sort them and send them to the designated sections. There is an exception of system 
downtime during which the specimens would be transported by a porter. However, this 
has been exceedingly rare in the past couple years. 
 
Nonetheless, we anticipate that the survey will help in effectively understanding 
and deducing root causes of noncompliance. We designed the survey questionnaire 
based on the results analysis and informal interviews with seniors of phlebotomy, 
nursing and anesthesia teams. We planned to distribute it by mid-March. However, the 
COVID 19 crisis has impeded the process. Hence, we were not able to conclude the 




questionnaire, and analyze the reasons accordingly in a couple of months from May 
2020.  
 
 No similar studies were conducted internally, as discussed previously in 
Chapter 2, or locally. With reference to the specimen collection manual of Hamad 
Medical Corporation, patient identifiers (patient full name and medical record number) 
are verbally verified upon specimen collection [53]. The process is not similar to Sidra 
Medicine in that collectors manually acknowledge collection in the system. Hence, we 
believe Sidra Medicine is the only hospital in Qatar that utilizes barcode-based 
identification system for scanning patient identification wristbands and specimen labels 
into the hospital’s information system.  
 
Lastly, we examined TML medical technologists compliance in detecting and 
rejecting dispatched samples upon specimen log-in. The new strict rejection policy of 
cancelling dispatched samples was effective on April 17, 2019. Because cancelled 
samples are not recorded in the TAT report, the data was retrieved from a separate 
report (Laboratory Cancellation Report). Only 15.1% of all dispatched samples, 
received post effective policy date, was cancelled by TML staff (Table 4). This reflected 
poor compliance to the new protocol. TML medical technologists are expected to attain 
high responsibility in assuring patient safety due to the nature of the service they 
provide. Presumably, staff could have read the email but did not remember to comply 
with the new process. Hence, staff need to be regularly reminded through emails and 





A new cancel code (LAB-Collection not documented) was added to the LIS in 
September 2019 to reflect cancellation of samples received in dispatched status. Strict 
adherence to using the new code facilitates selective data analysis when rejection report 
is executed or generated. TML technologists used the new code when cancelling the 3 
dispatched samples received in September to November, but did not select it when 
cancelling the sample received in December (Table 5). In addition, the cancel 
comments are discrepant among the rejected samples from May to December. For 
instance, no comment was added to 2 cancelled samples, and only 1 contained contact 
personnel ID (Table 5). Cancel comments should be harmonized among the 
technologist in order to control the process.  
 
Newly implemented rejection criteria by TML could be a factor of increased 
improvement rates in specimen collection by phlebotomists. This can be deduced 
through an independent study to draw an association between numbers of rejected TML 
specimens and/or numbers of submitted reports to the events reporting system, with 
regards to increased compliance frequencies of specimen collections. The association 
could not be properly examined as on average 1 sample was rejected per month; there 











CHAPTER 6: SUMMARY 
6.1 Conclusion  
Despite the implementation of barcode-based specimen collection wizard at Sidra 
Medicine, clinical staff fail to comply with policy/procedure in verifying patient and 
specimen accession identifications. In addition, medical technologists performed 
poorly in capturing and rejecting dispatched samples post acceptance criteria 
amendment. Sidra Medicine is an internationally accredited institution; thus, clinical 
departments must work collaboratively to assure that high level of patient safety is 
attained at all stages of patient flow.  
 
6.2 Limitations 
We highlighted possible limitations in our study. First, we could not find the specific 
roles of some collectors using Employee directory and Cerner database. As a result, we 
omitted about 2.6% of the data from the analysis. Second, we were unable to investigate 
the factors leading to the remarkable increase in compliance by phlebotomy team 
during the last quarter of 2019.  
 
6.3 Recommendations  
The investigation revealed that there is a clear need to improve patient identification 
during specimen collection. Support from all management and individual staff is 
necessary to improve patient safety. Thus, we target our recommendations to the 
clinical teams, Phlebotomy Department, Clinical Laboratory.  
6.3.1 Clinical Teams  
CAP recognizes that specimen acceptance and rejection criteria is a laboratory-




Thus, we recommend that all clinical staff, likely to collect specimens, be competent to 
specimen collection procedures.  
 
We recommend clinical leaders to investigate gaps in workflow, policy or 
training of personnel on the use of barcode technology. Hachesu et al identified multiple 
barriers to the use of the barcode systems, and suggested several recommendation 
which mainly targeted workflow and training of staff on the use of barcode system [24].   
 
In addition, we recommend performance of data-driven audits and observational 
audits at random periods. Data-driven audits can be conducted using reports submitted 
to the events reporting system. In addition, observational audits can improve behavior 
of specimen collection staff in adhering to the policy or procedure due to Hawthorne 
Effect [54].  
 
6.3.2 Phlebotomy  
We recommend phlebotomy seniors to amend specimen collection SOP to 
include non-electronic specimen collection procedure. We suggest adding a flowchart 
to depict the steps of specimen collection. We propose the adoption of specimen 
collection workflow illustrations from Saint Thomas Health, and non-electronic 
specimen collection procedure from Vanderbilt University Medical Center [55] [56]. 
We believe that manual acknowledgement of collections should include collectors staff 
ID, and not just initials, for accurate traceability. Moreover, we suggest the use of online 
learning modules to train and/or retrain staff. In addition, phlebotomy seniors should 




we recommend enforcement of periodic audits on specimen collection, and sharing 
results with nursing teams. 
 
6.3.3 Clinical Laboratory  
We recommend the participation of all laboratory sections in auditing specimens 
received. In addition, we suggest that all sections alter their rejection criteria to include 
dispatched specimens, and encourage their staff to utilize the events reporting system 
to document receiving of dispatched specimens. It has been shown that specimen 
collection errors reduced with increasing numbers of reports [57]. We also encourage 
managers, or anyone of superior authority, to request a change of Cerner’s Specimen 
Collection Wizard, to include warning when PPID is overridden, and/or add a drop-
down list to justify override practice.  
 
6.4 Future Direction 
In light of the limitations identified and the findings of the study, we recommend the 
following as future studies:  
- Use of data for continual improvement projects in TML, Sidra Medicine.  
- Interventional studies to compare 2019 results with 2020 results post 
implementation of a training program.  
- Understanding association between pre-analytical errors and events reporting 
system.  
- Identify mechanism to retrieve profiles of unknown collectors roles. 





- Nationwide study across all hospitals in Qatar to examine trends of 
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APPENDIX B: SURVEY QUESTIONNAIRE 
 
 
The purpose of this short questionnaire falls within quality improvement strategy of the 
Transfusion Medicine Laboratory. This survey will assess your practice of the process 
of patient and sample identification during blood specimen collection.  
 
The survey should be take less than 10 minutes to complete.  
 
We value your feedback, and we appreciate your time and input. As a sign of thanks 
feel free to include your email at the end of the survey to be entered in a prize draw to 
win a 75QAR Alshaya gift card. Note your email will ONLY be used for the draw and 
not to identify your answers. The project lead will have no way of identifying you, and 
your answers will remain completely anonymous. 
 
Our hope is that the results of this survey will help us identify opportunities to improve 
the blood collection process, thereby improving patient safety. 
 
Thank you in advance! 
 
1. Which department do you work in?  
i. Plaza D - OBTriage/WUC 
ii. Plaza ED - Urgent care & Trauma 
iii. 1A – HOOC 




v. 1A - IR & DI  
vi. IB – Ped Infusion 
vii. 1B - OR Pediatrics / Womens 
viii. 1B - PACU 
ix. 1B - DSU 
x. 1B/C – Pediatric Endoscopy Department (PED) 
xi. OR 
xii. 3B - PICU 
xiii. 3C & 4C - NICU 
xiv. 3D Birth Centre/WSCU 
xv. 4B Oncology/BMTU 
xvi. 5A - Peds Neuro & Gen Surg 
xvii. 5B - Peds Gen Surg/trauma/urology 
xviii. 5D - Ante Nat & Gyn 
xix. 6A - Peds Special Surg 
xx. 6B - Peds Specialty Med 
xxi. 6C - Post Partum 
xxii. 6D - Post Partum 
xxiii. 7A - Nephro & Dialysis 
xxiv. OPC 
xxv. Other (Please specify) 
xxvi.  
2. What is your job title?  





iii. Other (Please specify) 
3. How long have you worked at Sidra?  
a. 3 months or less 
b. 3-6 months 
c. 6-12 months 
d. More than one year 
e.  
4. Have you received training on how to document collection and correctly 
label a lab specimen at Sidra?  
a. No 
b. Yes (If yes, please specify the type of training that you receive) 
i. PowerChart training during induction 
ii. Supervised by a colleague at the bedside 
iii. Other (Please specify) 
 
5. How often do you collect specimens in your day to day practice?  
a. Always (at least once per shift) 
b. Frequently (at least once every couple of shifts) 
c. Often (at least once per week) 
d. Rarely (I encounter this maybe once per month) 
e. Never (I haven’t done this yet at Sidra) 
f.  











7. How often do you override barcode scanning of the patient ID band 
during sample collection?  
a. Always (with every collection) 
b. Frequently (every 2 or 3 collections) 
c. Often (every 3-10 collections) 
d. Rarely (less than 1 in 10 collections) 
e. Never (I haven’t done this yet at Sidra) 
f.  
8. Choose and rate the following reasons for overriding barcode scanning of 
the patient ID in order of importance/frequency. 
i. No patient ID available 
ii. Scan unable to read Patient ID 
iii. Scanner not available 
iv. Scanner not working 
v. I didn’t have appropriate training 
vi. Sample requested as STAT, and didn’t have time to scan 
vii. I open the specimen collection and override to see what to 
collect before the patient is in the room 





ix. Habit, that is how I learned to use the system 
x. It is easier and/ or faster and/or better for patients  
xi. Other (Please Specify) 
xii.  
9. How often do you override barcode scanning of the specimen barcode 
label during specimen collection?  
a. Always (with every collection) 
b. Frequently (every 2 or 3 collections) 
c. Often (every 3-10 collections) 
d. Infrequently (less than 1 in 10 collections) 
e. Never (I haven’t done this yet at Sidra) 
 
10. Choose and rate the following reasons for overriding barcode scanning of 
the specimen barcode label in order of importance/frequency. 
i. Scan unable to read specimen label 
ii. Scanner not available 
iii. Scanner not working 
iv. I didn’t have appropriate training 
v. Sample requested as STAT, and didn’t have time to scan 
vi. I document the collection after I send the specimen to the lab 
vii. Habit, that is how I learned to use the system 
viii. It is easier and/ or faster and/or better for patients  





11. What would help you to consistently use the barcode scanning features of 
the specimen collection wizard? 
 
 
Please indicate your email address only if you would like to be entered into the 
75QAR Alshaya gift card draw. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
